Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 4Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Cancer, Papillary 1Myasthenia Gravis 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Glioblastoma 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Surveys and Questionnaires 3Blood Specimen Collection 3veliparib 2Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Counseling 2Carboplatin 2prexasertib 1Zoledronic Acid 1Videotape Recording 1Telemedicine 1Taxes 1Tamoxifen 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Salpingectomy 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Ovariectomy 1Methods 1Letrozole 1Hysterectomy 1High-Throughput Nucleotide Sequencing 1Genotype 1Exercise Test 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Breast and Ovarian Cancer Syndrome × Genotype × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡